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Upregulation of CD44 and Hyaluronate Synthases by Topical
Retinoids in Mouse Skin
To the Editor:
CD44 is a ubiquitously expressed cell surface proteoglycan
that exists as numerous alternatively spliced and/or post-
translationally modified variants (Stamenkovic et al, 1991;
Screaton et al, 1992; Lesley et al, 1993; Bennett et al, 1995;
Zhou et al, 1999). CD44 appears to be a major cell surface
receptor for hyaluronate [(HA); Aruffo et al, 1990; Miyake
et al, 1990]. In a recent study, we have shown that two major
functions of CD44 in the mouse skin are the regulation of
keratinocyte proliferation in response to extracellular stimuli
and the maintenance of local HA homeostasis (Kaya et al,
1997).
HA is a high-molecular-weight linear polymer composed
of repeating units of D-glucuronic acid and N-acetyl-D-glu-
cosamine and is the principal component of the extracel-
lular matrix (Fraser and Laurent, 1989; Laurent and Fraser,
1992). HA is synthesized by hyaluronate synthase (HAS) at
the inner surface of the plasma membrane as long chains by
adding sugar residues at the reducing end, and then ex-
truded to the extracellular space (Prehm, 1984). Recently,
three distinct yet highly conserved genes encoding mam-
malian HAS, HAS1, HAS2, and HAS3, have been cloned
(Itano and Kimata, 1996; Spicer et al, 1996, 1997). In vitro
studies demonstrated that HAS enzymes are distinct from
each other in enzyme stability, elongation rate of HA, Km
values for D-glucuronic acid and N-acetyl-D-glucosamine,
and average chain length of synthesized HA (Itano et al,
1999). All HAS isoenzymes are expressed in the monolayers
of rat keratinocytes (Pienimaki et al, 2001), whereas human
keratinocytes are reported to express only HAS1 and HAS3
(Sayo et al, 2002) and mouse skin at least HAS1 and HAS2,
HAS1 being expressed more strongly in the epidermis and
HAS2 in the dermis (Sugiyama et al, 1998).
It has been shown that HA was selectively stimulated by
retinoids in porcine epidermis (King, 1984), hairless mouse
skin (Margelin et al, 1996), and human epidermis in skin
organ culture (Tammi et al, 1989). The mechanism of this
stimulation is not known. CD44 and HA expression show a
close correlation in human epidermis (Wang et al, 1992) and
rat epidermal keratinocyte organotypic cultures (Pasonen-
Seppanen et al, 2003). The effect of retinoids on CD44 and
HAS expression, which might contribute to retinoid-induced
HA stimulation, has not been studied.
In this study, we analyzed the effect of a topical retinoid,
retinaldehyde (RAL), on the protein and RNA expression of
CD44 and the RNA expression of HAS1, HAS2, and HAS3
in mouse skin. Pilot observations were also made in hu-
man skin on the CD44 protein expression. The experi-
ments described in the article were approved by
the Ethical Commission on Animal Experimentation of the
University of Geneva and the Cantonal Veterinary Office
of Geneva. The Guidelines on Animal Experimentation of
the Cantonal Veterinary Office of Geneva in accordance
with the Federal Legislation of Swiss Confederation were
followed.
Immunostaining of vehicle-treated back skin of SKH1
hairless mice revealed the standard expression of CD44 in
Abbreviations: HA, hyaluronate; HAS, hyaluronate synthase; RAL,
retinaldehyde
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basal and suprabasal keratinocytes (Fig 1A). No staining
was observed with the isotype control antibody (data not
shown). Topical application of 0.05% RAL for 7 d resulted in
an epidermal hyperplasia and a marked increase of CD44
expression in the skin (Fig 1B). RAL-treated human skin for
1 month also showed a significant epidermal hyperplasia
and an increase in epidermal CD44 expression (data not
shown). Other topical retinoids, retinol (ROL) and retinoic
acid (RA), also increased the protein expression of epider-
mal CD44 in mouse skin (data not shown). Northern blot
analysis showed an increase of CD44 RNA after RAL
(Fig 3a) but also after ROL and RA (data not shown).
To localize the HA in the mouse skin, the tissue sections
were first stained with colloidal iron, which is commonly
used to visualize mucopolysaccharides. In the skin sections
of RAL-treated mice, a strong blue staining was observed in
the spaces between the keratinocytes and in the superficial
dermis and this staining disappeared when the tissue sec-
tions were pretreated with hyaluronidase (data not shown).
We then used hyaluronate binding protein (HABP), which
can be used to specifically localize HA in tissue sections
(Ripellino et al, 1985). Histochemical analysis showed
marked binding of HABP to the epidermis and dermis in
RAL-treated mice, when compared with vehicle-treated
skin used as a control (Fig 2a). Pre-treatment of skin
sections with hyaluronidase abrogated HABP binding
(data not shown). Quantification of epidermal and dermal
HA by an enzyme-linked binding protein assay showed an
increase of HA in the RAL-treated mouse epidermis
when compared with untreated or vehicle-treated skin
(Fig 2b).
Northern blot analysis of RAL-treated mouse epidermis
revealed an increase in RNA transcripts of HAS 2 and 3
(Fig 3b). The signal for HAS1 mRNA was at the limit of
detection in both vehicle- and retinoid-treated skin (data not
shown).
We demonstrate here that topical application of a retinoid
increases the expression of CD44 in mouse skin. The in-
creased expression of CD44 accompanying epidermal
hyperplasia induced by a topically applied retinoid is asso-
ciated with an increase in epidermal and dermal HA and
with increased expression of HA-polymerizing enzymes.
Figure 1
Topical application of RAL increases the
protein expression of CD44 in mouse skin.
Histological sections of vehicle- (A) or retinalde-
hyde (RAL)- (B) treated SKH1 hairless mouse
back skin. Note the hyperplasia and increase in
CD44 expression in the epidermis. Groups of five
adult (43 mo old) SKH1 hairless mice (The Jack-
son Laboratory, Bar Harbor, Maine) were used.
RAL was used at the concentration of 0.05%
compounded in an oil-in-water cream (Saurat et
al, 1994). Retinoid cream samples of 0.5 g or the
vehicle were applied daily for 7 d on the back skin of SKH1 hairless mice. The daily amount of retinoid delivered corresponded to 250 mg. Twenty
hours after the last application, the animals were killed by decapitation, back skin was fixed in 10% phosphate-buffered formaldehyde, embedded in
paraffin, and processed for histological analysis. Sections were cut at 5 mm, mounted onto slides, dewaxed in xylene, and rehydrated in a graded
ethanol series. Endogenous peroxidase activity was blocked by incubating the sections with 0.03% H2O2 in anhydrous methanol for 45 min at room
temperature. Antigen demasking was performed by subjecting the sections to microwave treatment in citrate buffer (pH 6.0) for 20 min at 1200 W.
Then the sections were incubated with rat IgG2b isotype control (PharMingen, San Diego, California) for 30 min at room temperature and bio-
tinylated rabbit anti-rat antibodies (DakoCytomation, Glostrup, Denmark) for 30 min at room temperature, or only with biotinylated rat anti-mouse
CD44 antibodies (IgG2b; PharMingen, San Diego, California; 2.5 mg per mL) for 30 min at room temperature, washed thrice as above, and treated
with avidin–biotin–peroxidase for 30 min at room temperature. The sections were then washed with the buffer and incubated in 0.05% DAB (3,30-
diaminobenzidine; Sigma, St. Louis, Missouri) and 0.03% H2O2 in the phosphate buffer at room temperature. All sections were examined under a
Zeiss axiophot microscope (Zeiss, Oberkochen, Germany) using appropriate filters.
Figure 2
Topically applied RAL increases the HA content of mouse skin.
(a) Histological sections of vehicle- (A) or retinaldehyde (RAL)- (B) treat-
ed SKH1 hairless mouse back skin (three animals per group) stained
with hyaluronate (HA) binding protein (HABP). Strong epidermal and
dermal HABP reactivity was observed in RAL-treated skin (B). Histo-
chemistry was performed by using biotinylated HABP (Seikagaku Ko-
gyo, Tokyo, Japan; 25 ng per mL) instead of biotinylated anti-CD44
antibodies as described in the legend of Fig 1. (b) Epidermal HA content
in untreated and vehicle- or RAL-treated SKH1 hairless mouse back
skin quantified by an enzyme-linked binding protein assay. Quantifica-
tion of HA by this assay was performed using Corgenix Hyaluronic Acid
Quantitative Test Kit (Endotell, Allschwil, Switzerland) on mouse epi-
dermal extracts according to the manufacturer’s instructions. Post
mortem immediately frozen (801C) mouse skin samples were incu-
bated with NaBr (2 M) for 90 min at 37.51C to separate the epidermis
from the dermis. Contamination of the epidermis with the dermis was
excluded by standard histological analysis. The epidermal samples
were then put in extraction buffer containing 20 mM Tris/HCl (pH 7.5),
100 mM NaCl, 10 mM EDTA, 1% SDS, 10% glycerol, and protease
inhibitor cocktail (complete Boehringer, Biberach, Germany), minced,
polytron-homogenized, and sonicated on ice. Cell culture extracts were
treated with the same buffer. Homogenates were spun in a microfuge
for 20 min, and the soluble fraction was extracted and subjected to the
enzyme-linked binding protein assay. The results were represented as
the mean HA concentration  SD of three animals per group.
po0.01 versus RAL; po0.05 versus RAL (student’s t test).
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This is in accordance with previous observations on the
induction of HA accumulation by retinoids in mouse skin
(Margelin et al, 1996), in porcine epidermis (King, 1984), and
in human epidermis in skin organ culture (Tammi et al, 1989).
Previous studies on epidermal keratinocytes have indicated
that both HAS2 and HAS3 are regulated by a variety of
growth factors and cytokines. Epidermal growth factor
(EGF) and keratinocyte growth factor (KGF) upregulate
HAS2 and HAS3 in rat organotypic cultures (Karvinen et al,
2003; Pasonen-Seppanen et al, 2003); interferon-g (IFN-g)
upregulates HAS3 in cultured human keratinocytes (Sayo
et al, 2002); and transforming growth factor-b (TGF-b) sup-
presses HAS3 expression in human keratinocytes (Sayo
et al, 2002), whereas it upregulates HAS1 in mouse kera-
tinocytes (Sugiyama et al, 1998). In EGF-treated rat organo-
typic cultures, upregulation of HAS2 and 3 was associated
with accumulation of HA in the epidermis, upregulation of
epidermal CD44, elevated keratinocyte proliferation, and
decreased terminal differentiation (Pasonen-Seppanen et al,
2003). These observations are in line with our findings,
where RAL while stimulating epidermal HA synthesis, also
increased the expression of CD44 and resulted in epidermal
hyperplasia. It has been shown that the epidermal hyperpl-
asia induced by topical retinoids was linked to an RA re-
ceptor (RAR)-dependent heparin-binding epidermal growth
factor (HB-EGF) paracrine loop. (Xiao et al, 1999). Our ob-
servations indicate that the HA system might be associated
to this loop, with the transcriptional upregulation of CD44
and HAS. The integration of the retinoid-induced CD44 and
HAS modulation in the biological effects of topical retinoids
now requires further studies.
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